A hallmark of ccRCC is loss-of-function mutations in the von Hippel–Lindau (VHL) gene, which drive metabolic reprogramming toward aerobic glycolysis and excessive lactate production [104,105]. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.